Literature DB >> 4611129

Prophylactic treatment of migraine with propranolol. A clinical trial.

S E Borgesen, J L Nielsen, C E Moller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4611129     DOI： 10.1111/j.1600-0404.1974.tb02810.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  9 in total

1.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

2.  Beta-blockers in migraine prophylaxis.

Authors:  M Anthony
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

3.  Recurrent migraine after propranolol.

Authors:  R H Robson
Journal:  Br Heart J       Date:  1977-10

Review 4.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 5.  Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine.

Authors:  K E Andersson; E Vinge
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

6.  Comparison of the effects of dietary factors in the management and prophylaxis of migraine.

Authors:  Beyazit Zencirci
Journal:  J Pain Res       Date:  2010-07-23       Impact factor: 3.133

7.  A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Authors:  Jeffrey L Jackson; Elizabeth Cogbill; Rafael Santana-Davila; Christina Eldredge; William Collier; Andrew Gradall; Neha Sehgal; Jessica Kuester
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

8.  Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; Akira Kuriyama; Yachiyo Kuwatsuka; Sarah Nickoloff; Derek Storch; Wilkins Jackson; Zhi-Jiang Zhang; Yasuaki Hayashino
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

9.  Propranolol: A 50-Year Historical Perspective.

Authors:  A V Srinivasan
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.